Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast Pilot Study in Atopic Dermatitis
NCT01393158Phase 2Completed
- Sponsor
- Oregon Health & Science University
- Start
- May 2009
- Primary completion
- Jul 2011
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of apremilast in atopic dermatitis (AD), sponsored by Oregon Health & Science University. Started May 2009; status: completed.
02
Drugs
apremilast
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01393158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01393158.